Posted inBiotechnology
Examining Gut Biomarkers for Autism Detection
In recent years, the scientific community has made tremendous strides in understanding the complexities of Autism Spectrum Disorder (ASD). A…
Posted inBiotechnology
Assessing Resilience and Care Skills in Oncology Nurses
In the contemporary healthcare landscape, the importance of psychological resilience among oncology nurses cannot be overstated. The role of these…
Posted inBiotechnology
Exploring Chronic Hepatitis B and Fatty Liver Proteomics
Chronic hepatitis B virus (HBV) infection remains a leading cause of liver-related morbidity and mortality worldwide. Recent advancements in proteomics…
Posted inBiotechnology
New Distribution Record: Cymbalaria muralis in Kashmir Himalaya
In a remarkable stride toward biodiversity understanding, the discovery of Cymbalaria muralis (commonly known as wall pennywort) in the Kashmir…
Posted inBiotechnology
Pyrroloquinoline Quinone Alleviates Spinal Pain in Mice
In a groundbreaking study, researchers have identified a novel therapeutic application for Pyrroloquinoline quinone (PQQ), a naturally occurring compound known…
Posted inBiotechnology
New Drug Combination Reduces Mortality Risk in Advanced Prostate Cancer by 40%
A groundbreaking advancement in prostate cancer treatment offers new hope to men whose disease returns after initial attempts at surgery…
Posted inBiotechnology
AI Enhances Non-Invasive Sleep Stage Detection
In an era where sleep is increasingly recognized for its pivotal role in overall health and well-being, researchers are striving…
Posted inBiotechnology
Sex Differences in Energy Demand in Alzheimer’s Model
A groundbreaking study published in “Biology of Sex Differences” highlights the intricate dynamics of energy demand variations between male and…
Posted inBiotechnology
ESMO: Exelixis ‘franchise molecule’ reduces death risk by 20% in Stivarga comparison trial
Exelixis’ oral tyrosine kinase inhibitor (TKI) was tied to a 20% reduced risk of death from colorectal cancer, appearing to…
Posted inBiotechnology
Antibody-Drug Conjugates Enhance Outcomes in Advanced Triple-Negative Breast Cancer Patients Unsuitable for Immune Checkpoint Inhibitors
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial,…